ask="N/A"
ask_size="N/A"
average_daily_volume="21414"
bid="N/A"
bid_size="N/A"
book_value="-0.228"
change="+0.272"
change_from_200_day_moving_average="-0.434"
change_from_50_day_moving_average="0.273"
change_from_52_week_high="-2.208"
change_From_52_week_low="1.478"
change_in_percent="+9.037%"
close="3.282"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.670"
ebitda="-49.36M"
eps_estimate_current_year="-2.250"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-2.500"
ex_dividend_date="N/A"
float_shares="10019000"
high="3.715"
high_52_weeks="5.490"
last_trade_date="1/3/2017"
last_trade_price="3.282"
last_trade_size="500"
last_trade_time="3:59pm"
low="3.050"
low_52_weeks="1.804"
market_capitalization="77.38M"
moving_average_200_day="3.716"
moving_average_50_day="3.009"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.000"
open="3.050"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-11.670%"
percent_change_from_50_day_moving_average="+9.080%"
percent_change_from_52_week_high="-40.219%"
percent_change_from_52_week_low="+81.939%"
previous_close="3.010"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="23.819"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.190"
stock_exchange="NGM"
symbol="ONS"
volume="30034"
weeks_range_52="1.804 - 5.490"
